You are here

Healthcare Economics

 

For the fourth quarter of 2015, Boston Scientific’s sales hit $1.978 billion, representing a 10 percent jump in operational revenue compared with the same time period the previous year, while its adjusted earnings per share increased from $0.22 to $0.26.

 

Recent Headlines

Edwards Lifesciences agrees to repurchase $325 million of its common stock

Edwards Lifesciences announced on Feb. 4 that it had agreed to repurchase $325 million of its common stock from Morgan Stanley & Co. Edwards is funding the accelerated share repurchase using available cash, according to a news release.

Boston Scientific’s revenue and earnings per share increase in Q4

For the fourth quarter of 2015, Boston Scientific’s sales hit $1.978 billion, representing a 10 percent jump in operational revenue compared with the same time period the previous year, while its adjusted earnings per share increased from $0.22 to $0.26.

Merit Medical acquires vascular access system for $18.5 million

Merit Medical Systems announced this week that it has purchased the HeRO Graft vascular access system and its related assets from CryoLife for $18.5 million. 

Edwards Lifesciences’ TAVR sales increase 25 percent in fourth quarter

Led by strong sales in its transcatheter heart valve therapy (THV) division, Edwards Lifesciences’ fourth quarter revenue in 2015 increased 8.6 percent and its GAAP earnings per share increased 28.0 percent compared with the same period a year earlier.

Medtronic acquires privately held company to expand renal care business

Medtronic acquired Bellco on Feb. 1 to expand its recently formed renal care solutions business. Terms of the deal were not announced.

Sales of MitraClip device increase in Q4

For the fourth quarter of 2015, Abbott’s worldwide medical device sales increased 0.7 percent on an operational basis, while its vascular products revenue decreased 0.5 percent.

Best in KLAS: Merge sweeps top cardiology honors

Merge Healthcare claimed four awards—including the distinction of Category Leader in cardiology—in the Best in KLAS 2015/2016 honors.

St. Jude Medical’s revenue increases in 4Q, but cardiac rhythm management division lags

For the fourth quarter of 2015, St. Jude Medical’s revenue in its cardiac rhythm management division declined 10 percent on a constant-currency basis compared with the same time period in 2014. Meanwhile, revenue in its atrial fibrillation, cardiovascular and neuromodulation divisions increased 4 percent, 2 percent and 9 percent, respectively.

Medtronic forms partnership with municipal government in China

Medtronic has announced a partnership with a Chinese municipal government to expand access to diabetes treatments.

Sign of the Times Integrating Healthcare Delivery & Financial Systems

The merger of Pittsburgh’s WPAHS and insurance giant Highmark is a sign of the times and the start of a trend, says Tony G. Farah, MD, CMO of Allegheny Health Network (AHN), now an integrated healthcare delivery and finance system.

Pages